Search

everythinglearnresearchcommunity

for

Search:↓

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

The study suggests that complement activation, not immunoglobulins, may be important in erythema nodosum leprosum.

The combination of calcipotriene and betamethasone is more effective and has fewer side effects for treating psoriasis.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Ocrelizumab may cause delayed hair loss in some patients.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Patients need better information about the risks of long-term steroid use.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Clascoterone cream could be used for other skin conditions affected by hormones.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.